{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:47:06Z","timestamp":1778395626964,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"am","delay-in-days":414,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jnma.2023.11.008","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T12:16:51Z","timestamp":1700828211000},"page":"499-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Top five considerations for improving outcomes in black patients with heart failure: A guide for primary care clinicians"],"prefix":"10.1016","volume":"116","author":[{"given":"JaNae\u2019","family":"Richard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Sama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anekwe","family":"Onwuanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2038-7786","authenticated-orcid":false,"given":"Onyedika J.","family":"Ilonze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jnma.2023.11.008_bib0001","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jnma.2023.11.008_bib0002","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa0807265","article-title":"Racial differences in incident heart failure among young adults","volume":"360","author":"Bibbins-Domingo","year":"2009","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jnma.2023.11.008_bib0003","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2019.02.042","article-title":"Disparities in cardiovascular mortality related to heart failure in the United States","volume":"73","author":"Glynn","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jnma.2023.11.008_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003552","article-title":"National differences in trends for heart failure hospitalizations by sex and race\/ethnicity","volume":"10","author":"Ziaeian","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jnma.2023.11.008_bib0005","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.15420\/cfr.2022.02","article-title":"Unequitable heart failure therapy for black, hispanic and American-Indian patients","volume":"8","author":"Ilonze","year":"2022","journal-title":"Card Fail Rev"},{"issue":"7","key":"10.1016\/j.jnma.2023.11.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11034","article-title":"Health disparities in advanced heart failure treatment: the intersection of race and sex","volume":"3","author":"Young","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"19","key":"10.1016\/j.jnma.2023.11.008_bib0007","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.168.19.2138","article-title":"Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis","volume":"168","author":"Bahrami","year":"2008","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.jnma.2023.11.008_bib0008","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archinternmed.2009.40","article-title":"Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study","volume":"169","author":"Kalogeropoulos","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jnma.2023.11.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.hfc.2023.02.009","article-title":"Racial, ethnic, and gender disparities in valvular heart failure management","author":"Ilonze","year":"2023","journal-title":"Heart Fail Clin"},{"issue":"18","key":"10.1016\/j.jnma.2023.11.008_bib0010","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jnma.2023.11.008_bib0011","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"issue":"21","key":"10.1016\/j.jnma.2023.11.008_bib0012","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","article-title":"Cardiovascular health in African Americans: a scientific statement from the American Heart Association","volume":"136","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.jnma.2023.11.008_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007988","article-title":"Cumulative incidence of hypertension by 55 years of age in Blacks and Whites: the CARDIA study","volume":"7","author":"Thomas","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jnma.2023.11.008_bib0014","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/jamacardio.2017.0652","article-title":"Heterogeneity in blood pressure transitions over the life course: age-specific emergence of racial\/ethnic and sex disparities in the United States","volume":"2","author":"Hardy","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.jnma.2023.11.008_bib0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/HYPERTENSIONAHA.111.177410","article-title":"Progression is accelerated from prehypertension to hypertension in blacks","volume":"58","author":"Selassie","year":"2011","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.jnma.2023.11.008_bib0016","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.119.14059","article-title":"Primordial prevention of high blood pressure in childhood: an opportunity not to be missed","volume":"75","author":"Falkner","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.jnma.2023.11.008_bib0017","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jpeds.2007.09.022","article-title":"The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure","volume":"152","author":"Couch","year":"2008","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jnma.2023.11.008_bib0018","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/HYPERTENSIONAHA.113.01513","article-title":"Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring","volume":"62","author":"Fraser","year":"2013","journal-title":"Hypertension"},{"issue":"15","key":"10.1016\/j.jnma.2023.11.008_bib0019","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.288.15.1882","article-title":"Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program","volume":"288","author":"Whelton","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jnma.2023.11.008_bib0020","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jnma.2023.11.008_bib0021","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.104.492033","article-title":"Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994","volume":"113","author":"Barker","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jnma.2023.11.008_bib0022","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Maddox","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jnma.2023.11.008_bib0023","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jnma.2023.11.008_bib0024","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ehf2.12421","article-title":"Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey","volume":"6","author":"Brewster","year":"2019","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.jnma.2023.11.008_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000214","article-title":"Use of hydralazine-isosorbide dinitrate combination in African American and periodical race\/ethnic group patients with heart failure and reduced left ventricular ejection fraction","volume":"2","author":"Golwala","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jnma.2023.11.008_bib0026","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1215\/03616878-10041135","article-title":"Pursuing pharmacoequity: determinants, drivers, and pathways to progress","volume":"47","author":"Chalasani","year":"2022","journal-title":"J Health Polit Policy Law"},{"issue":"4","key":"10.1016\/j.jnma.2023.11.008_bib0027","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jnma.2023.11.008_bib0028","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jchf.2018.02.015","article-title":"African Americans are less likely to receive care by a cardiologist during an intensive care unit admission for heart failure","volume":"6","author":"Breathett","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"7","key":"10.1016\/j.jnma.2023.11.008_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009179","article-title":"Relation of household income to access and adherence to combination sacubitril\/valsartan in heart failure: a retrospective analysis of commercially insured patients","volume":"15","author":"Johnson","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"14","key":"10.1016\/j.jnma.2023.11.008_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022164","article-title":"Out-of-pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the United States","volume":"10","author":"Wang","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jnma.2023.11.008_bib0031","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10741-020-09979-z","article-title":"Clinical inertia in the treatment of heart failure: a major issue to tackle","volume":"26","author":"Verhestraeten","year":"2021","journal-title":"Heart Fail Rev"},{"issue":"3","key":"10.1016\/j.jnma.2023.11.008_bib0032","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCOUTCOMES.109.879478","article-title":"Treatment and risk in heart failure: gaps in evidence or quality?","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"10.1016\/j.jnma.2023.11.008_bib0033","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jchf.2017.12.007","article-title":"Medicare expenditures by race\/ethnicity after hospitalization for heart failure with preserved ejection fraction","volume":"6","author":"Ziaeian","year":"2018","journal-title":"JACC Heart failure"},{"issue":"7","key":"10.1016\/j.jnma.2023.11.008_bib0034","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004729","article-title":"Association of the affordable care act's medicaid expansion with care quality and outcomes for low-income patients hospitalized with heart failure","volume":"11","author":"Wadhera","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"10.1016\/j.jnma.2023.11.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6139","article-title":"Association of race\/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.jnma.2023.11.008_bib0036","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial","volume":"318","author":"Felker","year":"2017","journal-title":"JAMA"},{"issue":"10367","key":"10.1016\/j.jnma.2023.11.008_bib0037","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jnma.2023.11.008_bib0038","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11044","article-title":"Association of gender and race with allocation of advanced heart failure therapies","volume":"3","author":"Breathett","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jnma.2023.11.008_bib0039","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jnma.2023.11.008_bib0040","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.athoracsur.2019.03.073","article-title":"Racial disparities in patients bridged to heart transplantation with left ventricular assist devices","volume":"108","author":"Lui","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.jnma.2023.11.008_bib0041","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.hrthm.2008.12.018","article-title":"Ethnic and racial disparities in cardiac resynchronization therapy","volume":"6","author":"Farmer","year":"2009","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.jnma.2023.11.008_bib0042","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009745","article-title":"Racial inequities in access to ventricular assist device and transplant persist after consideration for preferences for care: a report from the REVIVAL study","volume":"16","author":"Cascino","year":"2023","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.jnma.2023.11.008_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005008","article-title":"Temporal trends in contemporary use of ventricular assist devices by race and ethnicity","volume":"11","author":"Breathett","year":"2018","journal-title":"Circul Heart Fail"},{"issue":"Suppl 2","key":"10.1016\/j.jnma.2023.11.008_bib0044","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/ajt.15278","article-title":"OPTN\/SRTR 2017 annual data report: heart","volume":"19","author":"Colvin","year":"2019","journal-title":"Am J Transplant"},{"issue":"22","key":"10.1016\/j.jnma.2023.11.008_bib0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013592","article-title":"Does race influence decision making for advanced heart failure therapies?","volume":"8","author":"Breathett","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jnma.2023.11.008_bib0046","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.athoracsur.2010.02.093","article-title":"The impact of race on survival after heart transplantation: an analysis of more than 20,000 patients","volume":"89","author":"Allen","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"22","key":"10.1016\/j.jnma.2023.11.008_bib0047","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.jacc.2022.03.338","article-title":"Electronic alerts to improve heart failure therapy in outpatient practice: a cluster randomized trial","volume":"79","author":"Ghazi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jnma.2023.11.008_bib0048","unstructured":"Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health: final report of the Commission on Social Determinants of Health. Accessed March 10, 2023. https:\/\/www.who.int\/social_determinants\/thecommission\/finalreport\/en\/."},{"issue":"9","key":"10.1016\/j.jnma.2023.11.008_bib0049","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014836","article-title":"Social determinants of health and 90-day mortality after hospitalization for heart failure in the REGARDS study","volume":"9","author":"Sterling","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.jnma.2023.11.008_bib0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/M17-2441","article-title":"Addressing social determinants to improve patient care and promote health equity: an American College of Physicians position paper","volume":"168","author":"Daniel","year":"2018","journal-title":"Ann Intern Med"},{"issue":"22","key":"10.1016\/j.jnma.2023.11.008_bib0051","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1161\/CIR.0000000000000767","article-title":"Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association","volume":"141","author":"White-Williams","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jnma.2023.11.008_bib0052","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11239-020-02268-4","article-title":"Effects of clinical depression on left ventricular dysfunction in patients with acute coronary syndrome","volume":"51","author":"Sama","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"10.1016\/j.jnma.2023.11.008_bib0053","first-page":"569","article-title":"Addressing challenges faced by underrepresented biomedical investigators and efforts to address them: an NHLBI-PRIDE perspective","volume":"114","author":"Ilonze","year":"2022","journal-title":"J Natl Med Assoc"},{"issue":"6","key":"10.1016\/j.jnma.2023.11.008_bib0054","doi-asserted-by":"crossref","DOI":"10.1007\/s12170-021-00670-y","article-title":"Racial and ethnic disparities in transthyretin cardiac amyloidosis","volume":"15","author":"Spencer-Bonilla","year":"2021","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"5","key":"10.1016\/j.jnma.2023.11.008_bib0055","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s10741-021-10162-1","article-title":"Epidemiology and clinical manifestations of cardiac amyloidosis","volume":"27","author":"Bajwa","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.jnma.2023.11.008_bib0056","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40119-021-00219-5","article-title":"Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM): a targeted literature review","volume":"10","author":"Rozenbaum","year":"2021","journal-title":"Cardiol Ther"},{"issue":"5","key":"10.1016\/j.jnma.2023.11.008_bib0057","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2010.02.006","article-title":"Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies","volume":"159","author":"Buxbaum","year":"2010","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.jnma.2023.11.008_bib0058","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The amyloidogenic V122I transthyretin variant in elderly black Americans","volume":"372","author":"Quarta","year":"2015","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jnma.2023.11.008_bib0059","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.119.045093","article-title":"Cost-effectiveness of tafamidis therapy for transthyretin amyloid cardiomyopathy","volume":"141","author":"Kazi","year":"2020","journal-title":"Circulation"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968423001451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968423001451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T04:33:32Z","timestamp":1732250012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968423001451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0027968423001451"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2023.11.008","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Top five considerations for improving outcomes in black patients with heart failure: A guide for primary care clinicians","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2023.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 National Medical Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}